Paola LaColla
8Patents
8h-index
3Co-inventors
51Inventor score
Filing activity: Jun 27, 2003 → Dec 6, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7608600B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Chemistry; Metallurgy | 144 | Expired |
| US7365057B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections | Chemistry; Metallurgy | 95 | Expired |
| US7635689B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Chemistry; Metallurgy | 93 | Expired |
| US7625875B2 | 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Human Necessities | 67 | Expired |
| US7547704B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Chemistry; Metallurgy | 64 | Expired |
| US7192936B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Chemistry; Metallurgy | 61 | Expired |
| US7384924B2 | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Chemistry; Metallurgy | 59 | Expired |
| US7662798B2 | 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections | Human Necessities | 55 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.